




























Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Lu, E. M-C., Ratnayake, J., & Rich, A. M. (2019). Assessment of proliferating cell nuclear antigen (PCNA)
expression at the invading front of oral squamous cell carcinoma. BMC Oral Health, 19(1), [233].
https://doi.org/10.1186/s12903-019-0928-9
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 29. Jul. 2021
RESEARCH ARTICLE Open Access
Assessment of proliferating cell nuclear
antigen (PCNA) expression at the invading
front of oral squamous cell carcinoma
Emily Ming-Chieh Lu, Jithendra Ratnayake* and Alison Mary Rich
Abstract
Background: Accurate prediction of the behaviour of oral squamous cell carcinoma (OSCC) is necessary to
determine prognosis and provide appropriate treatment. Therefore, it is important to investigate potential
prognostic markers to determine their predictive ability. Histological assessment of specific features at the invading
front of oral squamous cell carcinomas has shown to provide accurate and reproducible prognostic information.
Proliferating cell nuclear antigen (PCNA) is a nuclear marker known to reflect cell turnover and may be used as a
marker for tumour aggressiveness.
Methods: Twenty cases of OSCC were histologically assessed to evaluate the correlation between proliferating cell
nuclear antigen expression and invasive front grading. Each case was first assessed on a haematoxylin and eosin
stained slide and an invading front grading (IFG) score was determined. In order to obtain a PCNA score,
immunohistological staining was carried out using the peroxidase-labelled streptavidin-biotin technique with the
monoclonal antibody PC10.
Results: In all cases, tumour islands had a periphery of intensely stained proliferating cell nuclear antigen-positive
epithelial cells. The average IFG score was 8 ± 1.8, and the average PCNA score was 75% ± 11.2. Regression analysis
was done using data from the IFG score and PCNA score and taking the latter as the predictor variable. The
Pearson correlation coefficient was 0.134, with a p-value of 0.572.
Conclusion: Since the correlation between PCNA score and IFG score was not significant (p > 0.05), we conclude
that there is no association between cell proliferation at the invading tumour front and the histological grading of
OSCC.
Keywords: Proliferating cell nuclear antigen, Oral squamous cell carcinoma, Invasive tumour front, Cell proliferation,
Prognosis
Background
Oral cancer is a serious and growing problem in many parts
of the globe. Oral and pharyngeal cancer, grouped, is the
sixth most common cancer in the world [1]. According to
the global cancer statistics (GLOBOCAN 2018), 177,384
deaths were reported due to cancers of the lip and oral cav-
ity, and it is common in high-risk regions such as South
Asia [2, 3]. Despite advances in surgery and various adjunct-
ive therapies, there is no evidence to suggest that the
mortality of OSCC is increasing, and those that survive have
to cope with debilitating side effects of treatment [4, 5].
Accurate staging is essential to evaluate treatment proto-
cols and provide prognostic information for patients with
oral squamous cell carcinoma (OSCC). Conventionally, this
is based on the clinical assessment of tumour size, lymph
node involvement and presence of distant metastases, the
TNM system. The three parameters are tallied to give an
overall stage; the higher the stage the worse the prognosis.
While widely used, the TNM system has been criticised for
its inability to predict survival in OSCC [6]. Modifications
including the addition of the site of the tumour and a histo-
pathological assessment led to the development of the
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STNMP system with a weighted numerical score for all five
components [7]. While receiving some support, Langdon
et al. found that the STNMP system was no more accurate
in predicting survival than the TNM system [8] and
STNMP staging is not in common usage [9].
Altered rates of cell proliferation are one of the hall-
marks of tumour progression, and therefore, assessment
of this feature may be useful in predicting patient progno-
sis [10, 11]. Proliferating Cell Nuclear Antigen (PCNA) is
a nuclear protein and marker of cell proliferation. PCNA
is strongly related to prognosis and survival in most types
of solid malignancies, such as colorectal cancer and breast
cancer [12–14]. It is known to accurately reflect rates of
cellular proliferation and DNA synthesis since it accumu-
lates in late G1 and early S phase [15, 16]. A dysregulation
in cell proliferation could be assessed using PCNA, with
an increase in PCNA immunoreactivity associated with an
increase in cell proliferation [17].
Previous studies have demonstrated a positive correl-
ation between the expression of PCNA and histological
grading of OSCC. A difference in the expression of PCNA
was found between normal and dysplastic epithelium [18]
and between normal and malignant lesions [19]. Further-
more, PCNA expression showed a positive correlation
with histological grading [20], with an increase in PCNA
expression being associated with a poorly differentiated
tumour and a reduced expression of PCNA suggestive of
well-differentiated OSCC [21].
All of the aforementioned studies have, however, used
the conventional histological grading system, which as-
sesses the differentiation of the tumour as a whole. An
alternative histological assessment is the invasive front
grading (IFG) system which assesses the histological
grading of the tumour at the invasive front only. The in-
vasive tumour front (ITF) is a region of the tumour
which contains cells with higher proliferative activity
and [22] and a lower degree of differentiation [23].
Therefore, the ITF is considered the most important re-
gion of the tumour in determining prognosis and hence
it was proposed that the IFG system would allow more
accurate diagnosis and staging of cancer compared to
the conventional histological grading [10].
The IFG system comprises four morphologic features;
degree of keratinisation, nuclear polymorphism, pattern
of invasion and host response [10], with each feature
assigned a numerical value, generating an overall IFG
score. The minimum score of 4 is the lowest IFG score
obtainable and suggests a tumour with the best progno-
sis. Conversely, a maximum score of 16 suggests a
tumour with the worst possible prognosis. So far, no
studies have investigated the correlation between the ex-
pression of PCNA and IFG score at the ITF of OSCCs.
Therefore, the main aim of this study was to investigate
the correlation between the expression of PCNA at the
invasive tumour front and the IFG histological grading
in OSCCs.
Methods
Selection of study specimens
Ethical approval was obtained from the Faculty of Den-
tistry, University of Otago Human Ethics committee.
Specimens used for the study were all formalin-fixed,
paraffin-embedded tissues that had been diagnosed with
OSCC from the Oral Pathology Centre, Faculty of Den-
tistry, University of Otago. For this study, oral squamous
cell carcinoma (OSCC) arising in the oral cavity and lip
vermilion was used. Specimens from the skin of the lips
and face were excluded. The most recent cases of OSCC
were reviewed until 20 suitable cases had been collected
for the study. Inclusion criteria were the presence of the
ITF, intra-oral site, patient consent to the use of the bio-
logical material after diagnostic procedures were
complete for teaching and/or research purposes and
there being sufficient material in the block. For each
chosen case, a haematoxylin and eosin (H&E) slide was
histologically assessed, and a PCNA score was obtained
after immunohistological staining.
Histological evaluation
Each H&E stained slide was assessed histologically ac-
cording to the criteria outlined by Bryne [10] (Table 1).
An IFG score was thus generated, where an increase in
score is associated with a decrease in prognosis. Each H
&E slide was initially evaluated by the primary author
(EL) and later confirmed by AR, a consultant oral path-
ologist; this was repeated 2 weeks later to check the cor-
relation. Where there was a discrepancy between
examiners, the score from the most experienced exam-
iner (AR) was taken. Each histological sample was then
assigned an IFG score, as well as a conventional histo-
logical WHO grading [24].
Immunohistochemistry
A peroxidase-labelled streptavidin-biotin technique was
performed, similar to previously described [20, 25]. Briefly,
4 μm thick tissue sections were deparaffinsed in xylene,
rehydrated in graded absolute alcohols before washing in
running water. The pre-treatment step involved treating
the slides with proteinase K (DakoCytomation, Lot
00004344) for 10min, followed by immersion in citrate
buffer and heating in a microwave at 90 °C for 10min.
The slides were then allowed to cool to room temperature
before being washed under running water. All slides were
then treated with 3% H2O2 (BDH Laboratory Supplies
Poole, England, Lot K32950980) in methanol for 15min
to block the endogenous peroxidase activity. To block
nonspecific binding sites, 5% fetal calf serum (25ul frozen
aliquot FCS: 5 ml PBS) was added. This was followed by
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application of the monoclonal anti-PCNA antibody PC10
(DakoCytomation, Lot 00005087). Sections were then
treated with the biotinylated link and subsequently with the
streptavidin horseradish peroxidase (LSAB kit, DakoCyto-
mation, Lot 00003534). In order to visualise the peroxidase
activity, slides were saturated with the chromogen, diami-
nobenzidine hydrochloride (DAB, DakoCytomation, Lot
016067) in a ratio of 1ml DAB buffer: 1 drop DAB sub-
strate. All of the previous steps were followed by a wash in
PBS, unless otherwise stated. Finally, all slides were coun-
terstained with Gills haematoxylin, washed in Scotts tap
water before coverslips were applied.
All slides contained a section of normal epithelium to
serve as a both positive and an internal control. A nega-
tive control in which the primary antibody (PC10) was
omitted was included in each batch of slides stained.
Immunohistochemical evaluation: expression of PCNA
Each specimen was orientated by firstly identifying the epi-
thelium and then locating the tumour front in the deepest
invading area of the tumour. Counting was done systemat-
ically, whereby malignant keratinocytes in alternating high
power fields at the invading front were counted until a total
of 200 cells was reached. A PCNA positive cell was defined
as one with clear, distinct brown nuclear staining. The
number of positive cells was expressed as a percentage of
the total number counted to generate a PCNA score [25].
Intensity of PCNA expression was recorded with reference
to a known positive control and was reviewed and verified
by a specialist oral pathologist. Grade 1 denoted intense
PCNA staining, grade 2 moderate PCNA staining and
grade 3 indicated weak staining. The calibration process
was carried out on a total of six slides where agreement
was reached for each of the three grading intensities. Fol-
lowing calibration, each slide was assessed independently
by two examiners. The final number of PCNA positive cells
recorded for each slide was obtained from taking the aver-
age positive cell counts from the two examiners, EL and
AR. An appropriate level of inter-examiner agreement was
achieved across all slides (Cohen’s Kappa coefficient > 0.6).
To aid in the comparison between slides, images of the cells
in the invading front were captured digitally for later
reference.
Statistical analysis
Regression analysis was performed using Statistical Pack-
age for Social Studies software (SPSS version 24; IBM
Corporation, Armonk, NY, USA) to compare variables.
The level of significance was set at p < 0.05).
Results
Invasive front grading
At the invading front of each specimen, four morpho-
logical features were assessed on H&E slides as outlined
in Table 1. Each H&E section was assessed histologically
for their IFG scores according to the criteria outlined by
Bryne [10], and matched with their existing conventional
histological WHO grading [24]. The total IFG score and
the scores for each morphological feature for each speci-
men are shown in Table 2. The average IFG score was 8
with a standard deviation (SD) of 1.84. The mode score
was 7, and the score range was between 5 and 13 inclu-
sive. The mode score for each morphologic feature was
also calculated (Table 3). A mode score of 1 for “host re-
sponse” indicated a marked host response in most of the
specimens. Both “Degree of keratinisation” and “pattern
of response” had a mode score of 2, indicating that in
most cases 20–50% of cells were keratinised cells at the
tumour front, and there were infiltrating, solid cords,
bands or strands invading the connective tissue. Lastly,
“nuclear polymorphism” had a mode score of 3, indicat-
ing that 25–50% mature cells at the invading front
showed this feature (Table 3). Figure 1 shows the H & E
section of a specimen and its IFG score.
PCNA quantification and expression
Table 4 shows the PCNA score (%), and the intensity
of PCNA immunostaining expressed as a grade for
Table 1 The Invading tumour front grading system used to generate total IFG score, as developed by Bryne et al. [10]
Morphological feature Score
1 2 3 4
Degree of keratinisation Highly keratinised
(> 50% of the cells)
Moderately keratinised
(20–50% of the cells)
Minimal keratinisation
(5–20% of the cells)
No keratinisation
(0–5% of the cells)
Nuclear polymorphism Little nuclear polymorphism









Pattern of invasion Pushing, well delineated
infiltrating borders
Infiltrating, solid cords, bands
and /or strands
Small groups of cords of
infiltrating cells (n > 15)
Marked and widespread cellular
dissociation in small groups and /or




Marked Moderate Slight None
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each specimen. PCNA scores were computed by
quantifying the number of cells with a distinct brown
nuclear staining (PCNA positive cells) out of a total
of 200 cells counted at the invading front. Intensity
of staining was compared to a known control and de-
fined as 1 = intense, 2 = moderate or 3 = weak. The
average PCNA score was 75.0%, SD 11.2%. PCNA ex-
pression was intense (grade 1) in 45% of the cases,
moderate (grade 2) in 40% of the cases, and weak
(grade 3) in 15% of the cases. The mode intensity
score was 1.
In all cases, epithelial islands at the tumour front had a
periphery of intensely stained PCNA positive epithelial
cells, surrounding prickle cells (Fig. 2). The prickle cells
were in most cases moderately or weakly stained. How-
ever, no staining was observed in some specimens. Many
islands had an inner core of keratin, which was unstained.
Regression analyses
To assess the relationship between PCNA expression
and IFG and taking the intensity of staining as the pre-
dictor variable, the following model was generated:
IFG = 9.333–7.84 intensity. The p-value was 0.179, and
hence there was no association between intensity of
PCNA staining and IFG score in this study (Table 4).
Using PCNA score as the predictor variable, no signifi-
cant relationship was found between PCNA score and
Table 2 H&E histological evaluation using the IFG grading system [10]
OSCC cases Degree of keratinization Nuclear polymorphism Pattern of invasion Host response Total score
1) 1 3 2 1 7
2) 1 2 2 1 6
3) 2 1 1 1 5
4) 2 3 1 1 7
5) 2 4 1 2 9
6) 1 3 2 1 7
7) 2 3 2 2 9
8) 3 3 2 1 9
9) 2 3 3 1 9
10) 3 4 3 3 13
11) 2 3 2 3 10
12) 2 4 3 1 10
13) 2 3 2 1 8
14) 1 2 2 1 6
15) 1 2 3 1 7
16) 1 2 2 1 6
17) 1 4 2 2 9
18) 3 2 1 1 7
19) 2 2 2 2 8
20) 1 2 3 2 8
Table 3 Invasive front grading (IFG). Mode scores for individual
morphologic feature
Morphologic features Mode score
Degree of keratinisation 2
Nuclear polymorphism 3
Pattern of invasion 2
Host response 1
Fig. 1 H& E section showing malignant epithelial islands at the ITF
(×10 objective lens). The total IFG score was 7 (degree of
keratinisation = 1; nuclear polymorphism = 3; pattern of invasion = 2;
host response = 1)
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intensity of PCNA staining (p = 0.068) (Table 4). A sig-
nificant relationship (p = 0.012) between IFG score and
the conventional histological grading system was found
with regression analysis using IFG score as the predictor
variable (Table 4). To determine whether there was any
relationship between PCNA score and IFG score, PCNA
score was taken as the predictor variable (Table 4) and the
regression line generated follows the model: IFG = 6.343 +
0.022PCNA. This association was not significant (p >
0.05). The Pearson correlation coefficient (R) was 0.134
with a p-value of 0.572. In addition, the Spearman correl-
ation coefficient (ρ) was found to be 0.143; p = 0.547.
Discussion
The present study sought to assess the correlation be-
tween the expression of PCNA at the ITF and the IFG
score of OSCC cases from archival blocks. Our study
showed that there was an average of 75% PCNA positive
cells at the ITF. It is difficult to compare this finding
with that in the literature as most studies investigating
PCNA expression were exclusive to the ITF [17, 18, 26]
and the one study [27] which specifically examined the
expression of PCNA at the ITF did not stipulate the
WHO grading and the location of OSCC samples in the
oral cavity.
The intensity of PCNA positivity were mostly either
intense or moderate (45 and 40% of cases respectively).
This intense positivity observed at the periphery of the
malignant epithelial islands has been previously noted
[19, 26, 28] and suggests that this is the main site of cel-
lular proliferation. The variation in PCNA expression, as
observed in this study could be related to technical fac-
tors such as duration of fixation, size of tissue block and
Table 4 Summary of PCNA scores (%), intensity of PCNA staining, IFG scores and conventional histological grading scores for OSCC
cases
OSCC cases No. of PCNA +ve cells PCNA score % (out of 200) Intensity of staining IFG Score Conventional histological grading
1) 184 92 2 7 1
2) 103 51.5 3 6 1
3) 157 78.5 2 5 1
4) 169 84.5 2 7 1
5) 127 63.5 1 9 2
6) 137 68.5 3 7 1
7) 176 88 1 9 2
8) 163 81.5 1 9 2
9) 139 69.5 1 9 1
10) 148 74 2 13 2
11) 179 89.5 2 10 2
12) 149 74.5 1 10 1
13) 120 60 2 8 1
14) 165 82.5 1 6 1
15) 139 69.5 1 7 1
16) 147 73.5 2 6 1
17) 150 75 1 9 1
18) 116 58.2 3 7 2
19) 178 89 1 8 1
20) 154 77 2 8 1
Fig. 2 PCNA expression at the ITF showing intensely stained nucleus
(red arrow), surrounded by granular prickle cells (yellow arrows).
(×20 objective)
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the type of fixative [29]. While the latter was consistent
across all cases in this study, the first two factors could
not be controlled. Furthermore, the variability in marker
expression could be due to the fact that PCNA has a
long half-life of 20 h [30]. Therefore, it is possible that
non-cycling cells may show residual PCNA expression
and result in an overestimation of the proliferating
population.
The histological assessment using the IFG generated
scores suggested that most cases in this study had a rea-
sonable prognosis (Table 3). There was also positive as-
sociation between IFG scores and the conventional
histological grade, suggesting a consistency between the
two systems [10].
Overall, the study showed no association between the
expression of PCNA (percentage score and intensity
grading) and the IFG score at the ITF. While the data
seems to contrast with earlier studies which showed a
positive correlation between PCNA and histological
grade [21, 26], it is consistent with the findings from
Tsai and Jin which showed a lack of correlation between
PCNA expression and histological grading [17]. All of
the aforementioned studies have used the conventional
histological grading in its assessment, rather than the
ITF grading system employed in this study [10].
The lack of correlation between PCNA expression and
histological grading should not be unexpected, however,
given that there is evidence to suggest an absence of an as-
sociation between PCNA expression and patient survival
[31, 32]. A more recent study also showed that the expres-
sion of proliferation markers Ki67 and AgNOR at the ITF
were not associated with prognosis of OSCC [33]. How-
ever, overexpression of PCNA in conjunction with p53
was associated with OSCCs with a poor prognosis [27].
Similarly, overexpression of PCNA and EGFR was associ-
ated with poor survival [34]. This suggests that elevated
levels of PCNA, in the presence of increased expression of
a supplementary biomarker improves prognostic deter-
mination. Therefore, the long-term follow-up of our pa-
tient cases would determine whether the IFG grading
system and/ or PCNA score has any relationship with pa-
tient survival.
Conclusions
The study showed no correlation between the expression of
PCNA at the ITF and the IFG scores of OSCCs. Therefore,
there was no association between cell proliferation activity
and histological grading at the invading tumour front.
Abbreviations
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